About
General Partner of S32 (since 2017) and former CEO of Foundation Medicine through Roche's 2018 acquisition. Previously President and COO of Clarient. Holds an MD and focuses on personalized medicine and oncology.
Experience
- Section 32Managing Partnercurrent2017 — presentCa
- Foundation Medicine, Inc.Chairman2017 — 2018
- Foundation Medicine, Inc.CEO2011 — 2017
- Clarient, Inc.President and COO2007 — 2011
Education
- Thomas Jefferson University1993 — 1997
- Drexel University's LeBow College of BusinessMaster of Business Administration - MBA, Finance
- Boston CollegeBachelor’s Degree, Economics1983 — 1987
- Drexel University's LeBow College of BusinessMBA
Same school
Also attended Thomas Jefferson University5
Also attended Drexel University's LeBow College of Business10
Alex KatzGeneral Counsel at Ff Venture CapitalUdit DalalVP, Operations at LogosRichelle ParhamObvious Champion at Obvious VenturesEleni KytzidisAnalyst at Empactful CapitalClaudia DunnousChief Financial Officer at OUP (Osage University Partners)Jon WindermanChief Financial Officer at TruStage Ventures
+ 4 more
Also attended Boston College173
Pat GradyPartner at Sequoia CapitalDavid FialkowInvestment Team at General CatalystBijan SabetPersonal journalSteve MurrayAdvisor, Revolution Growth at RevolutionNatalie SchmitkeManaging Director Capital Networks at Burda Principal InvestmentsKerry HullChief Financial Officer & Chief Operating Officer at CincyTech
+ 167 more
Shared employers
Deals · 3
Twinstrand BiosciencesBoard seat
via S32 · filed Jun 2023 · $25.7M raise
Alpha SourceBoard seat
via S32 · filed Oct 2018 · $41.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at S32
Network4
Ainhoa Maiz
Principal at S32
Ayesha Arora
Venture Partner at S32
Bill Maris
General Partner, Founder at S32
Carlos Solórzano
Principal at S32
Investors connected to Mike in public investor directories — a warm-intro map.




.png)


























